Page last updated: 2024-11-03

prazosin and Bone Cancer

prazosin has been researched along with Bone Cancer in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, A1
Veeriah, V1
Xi, P1
Labella, R1
Chen, J1
Romeo, SG1
Ramasamy, SK1
Kusumbe, AP1
Ramachandra, M1
Ambudkar, SV1
Gottesman, MM1
Pastan, I1
Hrycyna, CA1

Other Studies

2 other studies available for prazosin and Bone Cancer

ArticleYear
Angiocrine signals regulate quiescence and therapy resistance in bone metastasis.
    JCI insight, 2019, 07-11, Volume: 4, Issue:13

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aging; Animals; Antineoplastic Agents; Bone Marrow; Bone Ne

2019
Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Molecular biology of the cell, 1996, Volume: 7, Issue:10

    Topics: 3T3 Cells; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; ATP Binding Cassette Transpor

1996